Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05). [electronic resource] by
- Swinnen, Lode J
- O'Neill, Anne
- Imus, Philip H
- Gujar, Sachin
- Schiff, David
- Kleinberg, Lawrence R
- Advani, Ranjana H
- Dunbar, Erin M
- Moore, Dennis
- Grossman, Stuart A
Publication details: Oncotarget Jan 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
12.
|
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. [electronic resource] by
- Brachman, David G
- Pugh, Stephanie L
- Ashby, Lynn S
- Thomas, Theresa A
- Dunbar, Erin M
- Narayan, Samir
- Robins, H Ian
- Bovi, Joseph A
- Rockhill, Jason K
- Won, Minhee
- Curran, Walter P
Producer: 20150603
In:
International journal of radiation oncology, biology, physics vol. 91
Availability: No items available.
|